NCT02356588View on ClinicalTrials.gov

A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions
Post-Operative Pain
Interventions
DRUG

Sufentanil Tablet 30 mcg

DRUG

Placebo Tablet

Trial Locations (4)

35660

Shoals Medical Trials, Inc, Sheffield

77004

Victory Medical Center, Houston

77024

Research Concepts, LLC, Houston

91106

Lotus Clinical Research, Pasadena

All Listed Sponsors
lead

Talphera, Inc

INDUSTRY

NCT02356588 - A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery | Biotech Hunter | Biotech Hunter